Monoamine OxidaseB inhibitor 2 is a potent, reversible, orally active and selectivemonoamine oxidaseB (MAO-B)inhibitor with anIC₅₀of 1.33 nM.Monoamine OxidaseB inhibitor 2 has antioxidant and anti-neuroinflammatory activities.Monoamine OxidaseB inhibitor 2 can across the blood-brain barrier (BBB), and can be used for Parkinson’s disease study^[1].

In cellular experiments, Monoamine Oxidase B inhibitor 2 (compound 8f; 0.5-10.0 μM) could significantly decrease the production of NO and TNF-α in LPS-stimulated BV-2 cells^[1].

In in vivo acute and subacute MPTP-induced mice model of Parkinson’s disease, Monoamine Oxidase B inhibitor 2 (compound 8f; 6.3-39.5 mg/kg; oral administration) could significantly improve most behavioral disorders, restore the dopamine content and decrease the MDA content in the mice striatum^[1].

314.35

C₁₉H₁₉FO₃

2807477-26-3

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.